ArticleEuropean journal of clinical pharmacology2003

Outcome trials of COX-2 selective inhibitors: global safety evaluation does not promise benefits.

Jorge Gomez Cerezo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.